S-TARget Achieves In Vivo Proof of Concept for Its Allergy Vaccine SG100

News   Apr 08, 2013

 
S-TARget Achieves In Vivo Proof of Concept for Its Allergy Vaccine SG100
 
 
FURTHER INFORMATION
 
 
 
 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE